Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays

Standard

Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. / Wiech, Thorsten; Nikolopoulos, Elisabeth; Weis, Roland; Langer, Rupert; Bartholomé, Kilian; Timmer, Jens; Walch, Axel K; Höfler, Heinz; Werner, Martin.

in: LAB INVEST, Jahrgang 89, Nr. 4, 01.04.2009, S. 385-97.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Wiech, T, Nikolopoulos, E, Weis, R, Langer, R, Bartholomé, K, Timmer, J, Walch, AK, Höfler, H & Werner, M 2009, 'Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays', LAB INVEST, Jg. 89, Nr. 4, S. 385-97. https://doi.org/10.1038/labinvest.2008.67

APA

Wiech, T., Nikolopoulos, E., Weis, R., Langer, R., Bartholomé, K., Timmer, J., Walch, A. K., Höfler, H., & Werner, M. (2009). Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. LAB INVEST, 89(4), 385-97. https://doi.org/10.1038/labinvest.2008.67

Vancouver

Bibtex

@article{fa4c26e390b1473688f6cdc4a67148e2,
title = "Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays",
abstract = "We performed genome-wide analysis of copy-number changes and loss of heterozygosity (LOH) in Barrett's esophageal adenocarcinoma by single nucleotide polymorphism (SNP) microarrays to identify associated genomic alterations. DNA from 27 esophageal adenocarcinomas and 14 matching normal tissues was subjected to SNP microarrays. The data were analyzed using dChipSNP software. Copy-number changes occurring in at least 25% of the cases and LOH occurring in at least 19% were regarded as relevant changes. As a validation, fluorescence in situ hybridization (FISH) of 8q24.21 (CMYC) and 8p23.1 (SOX7) was performed. Previously described genomic alterations in esophageal adenocarcinomas could be confirmed by SNP microarrays, such as amplification on 8q (CMYC, confirmed by FISH) and 20q13 or deletion/LOH on 3p (FHIT) and 9p (CDKN2A). Moreover, frequent gains were detected on 2p23.3, 7q11.22, 13q31.1, 14q32.31, 17q23.2 and 20q13.2 harboring several novel candidate genes. The highest copy numbers were seen on 8p23.1, the location of SOX7, which could be demonstrated to be involved in amplification by FISH. A nuclear overexpression of the transcription factor SOX7 could be detected by immunohistochemistry in two amplified tumors. Copy-number losses were seen on 18q21.32 and 20p11.21, harboring interesting candidate genes, such as CDH20 and CST4. Finally, a novel LOH region could be identified on 6p in at least 19% of the cases. In conclusion, SNP microarrays are a valuable tool to detect DNA copy-number changes and LOH at a high resolution. Using this technique, we identified several novel genes and DNA regions associated with esophageal adenocarcinoma.",
keywords = "Adenocarcinoma, Adult, Aged, Barrett Esophagus, Esophageal Neoplasms, Female, Gene Dosage, Genome-Wide Association Study, Humans, Loss of Heterozygosity, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide",
author = "Thorsten Wiech and Elisabeth Nikolopoulos and Roland Weis and Rupert Langer and Kilian Bartholom{\'e} and Jens Timmer and Walch, {Axel K} and Heinz H{\"o}fler and Martin Werner",
year = "2009",
month = apr,
day = "1",
doi = "10.1038/labinvest.2008.67",
language = "English",
volume = "89",
pages = "385--97",
journal = "LAB INVEST",
issn = "0023-6837",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays

AU - Wiech, Thorsten

AU - Nikolopoulos, Elisabeth

AU - Weis, Roland

AU - Langer, Rupert

AU - Bartholomé, Kilian

AU - Timmer, Jens

AU - Walch, Axel K

AU - Höfler, Heinz

AU - Werner, Martin

PY - 2009/4/1

Y1 - 2009/4/1

N2 - We performed genome-wide analysis of copy-number changes and loss of heterozygosity (LOH) in Barrett's esophageal adenocarcinoma by single nucleotide polymorphism (SNP) microarrays to identify associated genomic alterations. DNA from 27 esophageal adenocarcinomas and 14 matching normal tissues was subjected to SNP microarrays. The data were analyzed using dChipSNP software. Copy-number changes occurring in at least 25% of the cases and LOH occurring in at least 19% were regarded as relevant changes. As a validation, fluorescence in situ hybridization (FISH) of 8q24.21 (CMYC) and 8p23.1 (SOX7) was performed. Previously described genomic alterations in esophageal adenocarcinomas could be confirmed by SNP microarrays, such as amplification on 8q (CMYC, confirmed by FISH) and 20q13 or deletion/LOH on 3p (FHIT) and 9p (CDKN2A). Moreover, frequent gains were detected on 2p23.3, 7q11.22, 13q31.1, 14q32.31, 17q23.2 and 20q13.2 harboring several novel candidate genes. The highest copy numbers were seen on 8p23.1, the location of SOX7, which could be demonstrated to be involved in amplification by FISH. A nuclear overexpression of the transcription factor SOX7 could be detected by immunohistochemistry in two amplified tumors. Copy-number losses were seen on 18q21.32 and 20p11.21, harboring interesting candidate genes, such as CDH20 and CST4. Finally, a novel LOH region could be identified on 6p in at least 19% of the cases. In conclusion, SNP microarrays are a valuable tool to detect DNA copy-number changes and LOH at a high resolution. Using this technique, we identified several novel genes and DNA regions associated with esophageal adenocarcinoma.

AB - We performed genome-wide analysis of copy-number changes and loss of heterozygosity (LOH) in Barrett's esophageal adenocarcinoma by single nucleotide polymorphism (SNP) microarrays to identify associated genomic alterations. DNA from 27 esophageal adenocarcinomas and 14 matching normal tissues was subjected to SNP microarrays. The data were analyzed using dChipSNP software. Copy-number changes occurring in at least 25% of the cases and LOH occurring in at least 19% were regarded as relevant changes. As a validation, fluorescence in situ hybridization (FISH) of 8q24.21 (CMYC) and 8p23.1 (SOX7) was performed. Previously described genomic alterations in esophageal adenocarcinomas could be confirmed by SNP microarrays, such as amplification on 8q (CMYC, confirmed by FISH) and 20q13 or deletion/LOH on 3p (FHIT) and 9p (CDKN2A). Moreover, frequent gains were detected on 2p23.3, 7q11.22, 13q31.1, 14q32.31, 17q23.2 and 20q13.2 harboring several novel candidate genes. The highest copy numbers were seen on 8p23.1, the location of SOX7, which could be demonstrated to be involved in amplification by FISH. A nuclear overexpression of the transcription factor SOX7 could be detected by immunohistochemistry in two amplified tumors. Copy-number losses were seen on 18q21.32 and 20p11.21, harboring interesting candidate genes, such as CDH20 and CST4. Finally, a novel LOH region could be identified on 6p in at least 19% of the cases. In conclusion, SNP microarrays are a valuable tool to detect DNA copy-number changes and LOH at a high resolution. Using this technique, we identified several novel genes and DNA regions associated with esophageal adenocarcinoma.

KW - Adenocarcinoma

KW - Adult

KW - Aged

KW - Barrett Esophagus

KW - Esophageal Neoplasms

KW - Female

KW - Gene Dosage

KW - Genome-Wide Association Study

KW - Humans

KW - Loss of Heterozygosity

KW - Male

KW - Middle Aged

KW - Oligonucleotide Array Sequence Analysis

KW - Polymorphism, Single Nucleotide

U2 - 10.1038/labinvest.2008.67

DO - 10.1038/labinvest.2008.67

M3 - SCORING: Journal article

C2 - 18663352

VL - 89

SP - 385

EP - 397

JO - LAB INVEST

JF - LAB INVEST

SN - 0023-6837

IS - 4

ER -